Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
Clinical trial NCT07224399 · RECRUITING
Trial details
- NCT number
- NCT07224399
- Sponsor
- BrightGene Bio-Medical Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-09
- Primary completion
- 2026-05-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.